The nation of Zimbabwe has declined a substantial American health deal worth 367 million US dollars (272 million pounds) over five years because of Washington's insistence on sensitive biological samples.
This move was revealed following a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
A government spokesperson has since stated that the US was demanding access to biological samples for scientific study and profit while was unwilling to share the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable process of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged more talks to secure a agreement agreeable to all parties so the nation's vital HIV programme can be sustained.
Wider Implications
Zimbabwe's decision comes after a similar situation in Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the security of citizens' health data.
Since resuming office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance transparency and accountability.
Based on statements, Sixteen nations in Africa have to date signed these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to provide its genetic material and health information for a long time, with no corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"In essence, our country would supply the basic resources for scientific discovery with no certainty that the end products would be available to our population should a new health crisis arise."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems previously established via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with potential pandemics.
"This framework is intended to ensure that when a country provides its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to create them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," he added.
"We welcome ongoing discussions with our American counterparts on how future co-operation could be structured in a way that honours the independence and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but urged that talks need to persist considering much of the nation's HIV programmes were funded by international support.
"Where specific concerns arise, including those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," it commented.
The halted deal underscores the continuing debate between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.